115 related articles for article (PubMed ID: 21677225)
1. Duloxetine-induced subcortical growth in a patient with major depressive disorder and panic disorder.
Lai CH
J Neuropsychiatry Clin Neurosci; 2011; 23(2):E42-3. PubMed ID: 21677225
[No Abstract] [Full Text] [Related]
2. Duloxetine-related growth of putamen and brainstem in first-onset drug-naive major depressive disorder with panic disorder: a case series.
Lai CH
J Neuropsychiatry Clin Neurosci; 2011; 23(2):E40-1. PubMed ID: 21677224
[No Abstract] [Full Text] [Related]
3. Duloxetine related effects of brain structure on a patient of major depressive disorder with panic disorder.
Lai CH
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):240-1. PubMed ID: 19833160
[No Abstract] [Full Text] [Related]
4. Duloxetine's modest short-term influences in subcortical structures of first episode drug-naïve patients with major depressive disorder and panic disorder.
Lai CH; Wu YT
Psychiatry Res; 2011 Nov; 194(2):157-62. PubMed ID: 21820879
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine's effects in resting functional magnetic resonance imaging of first-episode, drug-naive major depressive disorder with panic disorder patients.
Lai CH
J Neuropsychiatry Clin Neurosci; 2011; 23(3):E10-1. PubMed ID: 21948903
[No Abstract] [Full Text] [Related]
6. Increases in amplitude of low-frequency fluctuations in left fronto-parietal area after duloxetine therapy in first-episode, drug-naïve, major depressive disorder with panic disorder patients.
Lai CH
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E24-5. PubMed ID: 23037667
[No Abstract] [Full Text] [Related]
7. A subtle grey-matter increase in first-episode, drug-naive major depressive disorder with panic disorder after 6 weeks' duloxetine therapy.
Lai CH; Hsu YY
Int J Neuropsychopharmacol; 2011 Mar; 14(2):225-35. PubMed ID: 20663271
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder.
Lai CH
J Clin Psychopharmacol; 2010 Feb; 30(1):88-9. PubMed ID: 20075662
[No Abstract] [Full Text] [Related]
9. Duloxetine in the treatment of panic disorder.
Crippa JA; Zuardi AW
Int J Neuropsychopharmacol; 2006 Oct; 9(5):633-4. PubMed ID: 16288682
[No Abstract] [Full Text] [Related]
10. Increased anterior cingulate regional homogeneity after duloxetine therapy in first-episode, drug-naïve, major depressive disorder with panic disorder patients: a case series.
Lai CH
J Neuropsychiatry Clin Neurosci; 2012; 24(3):E13-4. PubMed ID: 23037661
[No Abstract] [Full Text] [Related]
11. Duloxetine fights major depressive disorder.
Wimett L; Laustsen G
Nurse Pract; 2005 Mar; 30(3):6-7. PubMed ID: 15753808
[No Abstract] [Full Text] [Related]
12. Frontal regional homogeneity increased and temporal regional homogeneity decreased after remission of first-episode drug-naïve major depressive disorder with panic disorder patients under duloxetine therapy for 6 weeks.
Lai CH; Wu YT
J Affect Disord; 2012 Feb; 136(3):453-8. PubMed ID: 22137181
[TBL] [Abstract][Full Text] [Related]
13. Response to duloxetine in a depressed, treatment-resistant adolescent female.
Delgado SV; Saldaña SN; Barzman DH; Coffey B
J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):889-94. PubMed ID: 18315460
[No Abstract] [Full Text] [Related]
14. Atypical Stevens-Johnson syndrome in an adolescent treated with duloxetine.
Strawn JR; Whitsel R; Nandagopal JJ; Delbello MP
J Child Adolesc Psychopharmacol; 2011 Feb; 21(1):91-2. PubMed ID: 21309700
[No Abstract] [Full Text] [Related]
15. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.
Mancini M; Perna G; Rossi A; Petralia A
Expert Opin Pharmacother; 2010 May; 11(7):1167-81. PubMed ID: 20402555
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the acute and continuation treatment of major depressive disorder.
Bochsler L; Olver JS; Norman TR
Expert Rev Neurother; 2011 Nov; 11(11):1525-39. PubMed ID: 22014130
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine.
Preskorn SH
J Psychiatr Pract; 2004 Nov; 10(6):375-85. PubMed ID: 15583519
[No Abstract] [Full Text] [Related]
18. Measurement of pain and medication effect in a study of duloxetine.
Griffith JM; Hasley JP; Severn DG
J Clin Psychiatry; 2008 Jun; 69(6):1022. PubMed ID: 18684005
[No Abstract] [Full Text] [Related]
19. A word of caution about the implied role for duloxetine in pain management.
Leo RJ
J Clin Psychiatry; 2003 Oct; 64(10):1270. PubMed ID: 14658982
[No Abstract] [Full Text] [Related]
20. [Brief case report. Duloxetine in Cotard syndrome].
Kozian R
Psychiatr Prax; 2005 Nov; 32(8):412-3. PubMed ID: 16342026
[No Abstract] [Full Text] [Related]
[Next] [New Search]
